| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/24/2003 | US20030138406 Novel lactobacillus paracasei subsp. paracasei strain antibacterial against helicobacter pyroli and escherichia coli 0157:h7 |
| 07/24/2003 | US20030138397 Anionic polymers as toxin binders and antibacterial agents |
| 07/24/2003 | US20030136698 Medicinal product package for eradication therapy |
| 07/24/2003 | CA2474239A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | CA2474127A1 4-oxo-4, 7-dihydrofuro¬2,3-b|pyridine-5-carboxamide antiviral agents |
| 07/24/2003 | CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii |
| 07/24/2003 | CA2473229A1 Selective melanin-concentrating hormone type -1 receptor agonists |
| 07/24/2003 | CA2472993A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents |
| 07/24/2003 | CA2472468A1 Construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus |
| 07/24/2003 | CA2472459A1 Use of cox-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections |
| 07/24/2003 | CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | CA2471744A1 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | CA2471702A1 Human monoclonal antibodies against cd30 |
| 07/24/2003 | CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | CA2470649A1 Mmp inhibitors |
| 07/24/2003 | CA2470421A1 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | CA2469715A1 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 07/24/2003 | CA2468610A1 Method for reducing morbidity and mortality in critically ill patients |
| 07/24/2003 | CA2467764A1 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | CA2464805A1 D-tagatose as an anti-biofilm agent |
| 07/24/2003 | CA2464472A1 Antibody targeting compounds |
| 07/24/2003 | CA2464131A1 Compositions and methods for controlled release |
| 07/24/2003 | CA2463008A1 Efficient protein expression system |
| 07/23/2003 | EP1329459A2 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon |
| 07/23/2003 | EP1329457A2 Antipicornaviral compounds, their preparation and use |
| 07/23/2003 | EP1329223A1 Expression potentiator for protein synthesis regulatory gene |
| 07/23/2003 | EP1329220A1 Cytokine related treatments of disease |
| 07/23/2003 | EP1328641A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328622A2 Protein c or activated protein c-like molecules |
| 07/23/2003 | EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 07/23/2003 | EP1328540A2 Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150 |
| 07/23/2003 | EP1328535A1 Macrolides |
| 07/23/2003 | EP1328534A2 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance |
| 07/23/2003 | EP1328516A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 07/23/2003 | EP1328514A1 Amide derivatives as nmda receptor antagonists |
| 07/23/2003 | EP1328507A1 Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 07/23/2003 | EP1328298A1 Methods and compositions for modulating t cell activation and uses thereof |
| 07/23/2003 | EP1328284A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 07/23/2003 | EP1328282A1 Efficient method for producing compositions enriched in anthocyanins |
| 07/23/2003 | EP1328272A1 Nf-kappa-b inhibitors |
| 07/23/2003 | EP1328245A1 Dental care compositions |
| 07/23/2003 | EP1242388B1 Method for production of a triazolinethione derivative |
| 07/23/2003 | EP1228073B1 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 07/23/2003 | EP1140199B1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/23/2003 | EP1107741B1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 07/23/2003 | EP1089753B1 Use of a dipeptide for stimulating repair processes |
| 07/23/2003 | EP1069913B1 Gelling ophthalmic compositions containing xanthan gum |
| 07/23/2003 | EP1056742B1 Anti-viral pyrimidine derivatives |
| 07/23/2003 | EP1053012B1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections |
| 07/23/2003 | EP1015452B1 Optionally protected 3-hydroxymethyl carbapenems and synthesis |
| 07/23/2003 | EP0975636B1 1h-pyrazolo[3,4-d]pyrimidine-4,6-diones as t-cell proliferation inhibitors |
| 07/23/2003 | EP0956033B1 Total synthesis of the amino hip analogue of didemnin a |
| 07/23/2003 | EP0855919B1 Induction of mucosal immune responses by vitamin d3 and antigen-encoding dna complexe to cationic lipid |
| 07/23/2003 | EP0822817B1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 07/23/2003 | EP0811011B1 Carbohydrate conjugated bio-active compounds |
| 07/23/2003 | EP0756630B1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 07/23/2003 | EP0643770B1 Helicobacter pylori cytotoxin associated immunodominant antigen useful for vaccines and diagnostics |
| 07/23/2003 | EP0628044B1 Therapeutic nucleosides |
| 07/23/2003 | CN1432022A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/23/2003 | CN1432020A 嘌呤衍生物 Purine derivatives |
| 07/23/2003 | CN1432019A Hygromycin derivatives for treatment of bacterial and protozoal infections |
| 07/23/2003 | CN1432016A Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 07/23/2003 | CN1432014A Triazole compounds having amide linkage |
| 07/23/2003 | CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432011A Benzoamide piperidine compounds as substance P antagonists |
| 07/23/2003 | CN1432008A Quinolonecarboxylic acid derivative |
| 07/23/2003 | CN1432007A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 07/23/2003 | CN1432001A 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 07/23/2003 | CN1431998A Growth hormone secretagogues |
| 07/23/2003 | CN1431995A Antipicornaviral compounds and compsns. their pharmaceutical uses, and materials for their synthesis |
| 07/23/2003 | CN1431913A Vaccine compsn. |
| 07/23/2003 | CN1431907A Method of treating hepatitis delta viral infection |
| 07/23/2003 | CN1431897A Peptide deformylase inhibitors |
| 07/23/2003 | CN1431311A Method for expressing thymopolypeptides šŒ1 by use of escherichia coli and its application |
| 07/23/2003 | CN1431212A Similar of sulph DCK, its synthesizing method and applications |
| 07/23/2003 | CN1431211A Amine salt of cefathiamiding, its preparing method and application |
| 07/23/2003 | CN1431203A 7-substitution-1-hero hydrogenated-2-ketone and ramification as well as its synthesizing method and usage |
| 07/23/2003 | CN1431200A Compound of phycocyania of blue-green algae, its preparing method and usage |
| 07/23/2003 | CN1431020A Epiposition vaccine of gene engineering for influenza virus and its preparing method |
| 07/23/2003 | CN1431018A Syncretic protein product of human methionine enkephalin interferon alpha-m with anti-HSV infection and easy pain |
| 07/23/2003 | CN1431013A Prepared Chinese medicine for curing and preventing AIDS disease |
| 07/23/2003 | CN1431012A Externally used Chinese herbal medicine for treating gynecology inflammation |
| 07/23/2003 | CN1431011A Oral medicine for curing hepatitis |
| 07/23/2003 | CN1431008A Medicine for treating various fungal skin disease or bromidrosis |
| 07/23/2003 | CN1431007A Combination of external remedy for treating skin disease and venereal disease |
| 07/23/2003 | CN1430991A Medicine combination for treating chronic hepatitis B |
| 07/23/2003 | CN1430990A Detoxification tea of white bamboo |
| 07/23/2003 | CN1430988A Chinese herbal medicine for treating smelly feet and its preparing method |
| 07/23/2003 | CN1430987A Chewing tablet of hydrochloric bastardtoad flax and creation technique |
| 07/23/2003 | CN1430986A Compound zedoary oil ointment and its preparing method |
| 07/23/2003 | CN1430985A Intravenous drip and injection liquid of hydrochloric bastardtoad flax and creation technique |
| 07/23/2003 | CN1430984A Detoxification capsule and its prodn. methods |
| 07/23/2003 | CN1430982A Capsule of astragalus and honey as well as its preparing technique |
| 07/23/2003 | CN1430981A Zedoary oil product of virus safe medicine and its preparing method |
| 07/23/2003 | CN1430980A Chinese medicine ÔÇÿKeZilingÔÇÖ and its product |
| 07/23/2003 | CN1430979A Prescription combined with Chinese herbal medicine for treating AIDS |